Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001 Meeting Abstract
| Authors: | Shaw, A.; Riely, G. J.; Bang, Y. J.; Kim, D. W.; Camidge, D. R.; Shapiro, G. I.; Usari, T.; Wang, S. C.; Wilner, K.; Clark, J. W.; Ou, S. H. I. |
| Abstract Title: | Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001 |
| Meeting Title: | 2018 European Lung Cancer Congress (ELCC) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Apr 10-13 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-04-01 |
| Start Page: | mdz063.005 |
| Language: | English |
| ACCESSION: | WOS:000478089000106 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz063.005 |
| Notes: | Meeting Abstract: 107O -- Appears on pages ii41-ii42 of the abstract book -- Source: Wos |
